We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

SIGN UP FOR ACTEMRA INFORMATION ALERTS

To receive updates regarding Actemra availability, please enter your email address and additional information below.

* indicates required
Please indicate your field *